These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Specific site involvement in fixed drug eruption. Ozkaya-Bayazit E J Am Acad Dermatol; 2003 Dec; 49(6):1003-7. PubMed ID: 14639376 [TBL] [Abstract][Full Text] [Related]
18. Bullous acral eruption related to secukinumab. Blackcloud P; Dupuy E; Kang Y; Smart C; Hsiao J Dermatol Online J; 2019 Jun; 25(6):. PubMed ID: 31329391 [TBL] [Abstract][Full Text] [Related]
19. [Dermatologic toxicity to sorafenib]. Velázquez D; de la Cueva P; Zamberk P; Lázaro P Actas Dermosifiliogr; 2009; 100(6):518-20. PubMed ID: 19709563 [No Abstract] [Full Text] [Related]
20. Fixed drug eruption due to cotrimoxazole. Bharija SC; Belhaj MS Australas J Dermatol; 1989; 30(1):43-4. PubMed ID: 2535011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]